Home News & Events Events Events Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Previous 1 … 2 3 4 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc Osivelotor is an oral investigational drug for the treatment of sickle cell disease (SCD) designed to inhibit hemoglobin polymerization. In a phase 1, open-label ADME study conducted in healthy participants at ICON’s cli... 12 Jun View post View webpage ICON Plc Visit us at DIA Philadelphia, 14–18 June, Booth \#1426, and explore ICON’s solutions spanning AI-driven trials, regulatory strategy, faster start-up and high-performing site models. https://ow.ly/1VF950Z29B7 12 Jun View post View webpage ICON Plc We’re pleased to be part of ACRO’s Good Clinical Podcast focused on advancing rare disease research through AI innovation and patient trust. In the discussion, ICON’s Tanya Binette highlights where AI is delivering valu... 12 Jun View post View webpage ICON Plc More than a decade ago, Yordan Zahariev joined ICON as a Clinical Trial Assistant. Today, he leads one of ICON's largest CTA teams in Bulgaria as a Clinical Operations Manager. In our latest career story, Yordan reflect... 12 Jun View post View webpage ICON Plc Attending CTO East Coast in Boston? Join Padma Varadharajan on 30 June at 9:30am for her core session entitled: “Practical considerations for navigating the landscape of global oncology trials in 2026 and beyond.” This ... 11 Jun View post View webpage ICON Plc Steatotic (fatty) liver disease is a silent global epidemic, often underdiagnosed despite its growing impact. Beyond the liver, it is closely linked to obesity, type 2 diabetes andhyperlipidaemia, driving significant car... 11 Jun View post View webpage ICON Plc Site performance remains one of the most critical drivers of trial success. Through FIRECREST, ICON is enhancing site engagement, improving consistency and delivering stronger study execution at scale. Visit Booth \#1426... 10 Jun View post View webpage ICON Plc ICON is proud to sponsor the SOLAR conference. Our hepatology specialists will be on-site (25-27 June), talking with peers about the practical side of running liver disease trials from AI-driven site selection to imagi... 9 Jun View post View webpage ICON Plc Last week, we proudly celebrated a significant milestone, 30 years of ICON Germany. Over the past three decades, our teams in Germany have played an important role in advancing clinical research and supporting customer... 9 Jun View post View webpage ICON Plc Meet the ICON team at #OCTUK26 tomorrow. Our team is gearing up for industry updates and dynamic discussions on how we can help drive success for your clinical trial. Visit us at booth \#42 to explore our expertise spa... 8 Jun View post View webpage ICON Plc Celebrating 20 years of ICON in Poland. Since our Polish branch was established in Warsaw in 2006, ICON Poland has grown into a team of more than 1,800 employees across Warsaw, Gdańsk, and remote working locations. Ove... 5 Jun View post View webpage ICON Plc ICON Biotech is sponsoring #OCTUK26, taking place 9–10 June in London. Visit us at booth \#42 to learn how we’re advancing clinical trial solutions through innovation, operational excellence and deep therapeutic experti... 5 Jun View post View webpage
